Visual summary of key quantitative findings

Evidence stack (what the paper shows — each claim followed by the primary citation)

• Human datasets: GSEA reanalysis shows dysregulated neddylation-related gene sets in ICM/NICM; complementary Western blot/qPCR on small patient cohorts (NF n=5; DCM n=6; ICM n=5) reports altered high-MW neddylated proteins and reduced neddylated cullins in disease hearts Paper: human data and GSEA
• Adult cardiomyocyte NAE1 KO phenotype (genetics): cardiomyocyte-restricted tamoxifen-induced NAE1 deletion (αMHC-MerCreMer : Nae1 flox/flox) → progressive cardiac dysfunction (EF drop by 8–10 wks), dilated cardiomyopathy, increased HW/BW, necrosis, and lethality by ~90 days post-TAM Paper: NAE1KO mouse phenotype
• RNA-seq and metabolic shift: bulk ventricle RNA-seq (CTL n=4 vs NAE1KO n=4) found 849 up and 662 down genes; hallmark GSEA: oxidative phosphorylation and fatty acid metabolism down, glycolysis up, ROS & inflammatory pathways up → consistent with impaired mitochondrial function and metabolic reprogramming Paper: RNA-seq metabolic results
• Mitochondrial morphology & bioenergetics: TEM + 3D reconstructions show larger/hyperfused mitochondria and increased mitophagic vesicles; aspect ratio and form factor increased; TMRM membrane potential reduced; Seahorse tests in MLN-treated cardiomyocytes show lower basal & maximal respiration, ATP production and spare capacity Paper: TEM + respiration data
• Mitophagy impairment: decreased phospho-S65-ubiquitin (pS65-Ub) colocalizing to mitochondria, decreased mitochondrial pUb upon MLN4924 or NAE1 deletion, reduced mt-Keima red/green puncta in vivo and in cells → interpreted as impaired progression of mitophagy despite increased lysosomal markers (LAMP1) and LC3-II/p62 (accumulation) Paper: mitophagy readouts
• Cullin involvement (candidate mediators): CUL2 and CUL4b localize to mitochondria; siRNA knockdown of CUL2 or CUL4b reduces CCCP-induced mitochondrial pUb (like MLN) without reproducing MLN bioenergetic defects → suggests Cullin-dependent regulation of mitochondrial ubiquitination/mitophagy downstream of neddylation Paper: Cullin siRNA results
• Genetic interactions with DRP1 and MFN2: NAE1 loss exacerbates DRP1KO cardiomyopathy (NDDKO → earlier lethality and worse EF) and NAE1/MFN2 double KO has early protection (less hyperfusion) but still leads to heart failure and earlier death than NAE1KO — data indicate complex interplay between neddylation and mitochondrial dynamics proteins Paper: genetic interaction models

Concise mechanistic model (paper's proposal)

Neddylation (NAE1-dependent) is required to activate mitochondrial-localized CRLs (e.g., CUL2/CUL4b) that support ubiquitination signals on damaged mitochondria (pS65-Ub amplification), enabling recruitment of mitophagy machinery; loss of neddylation uncouples ubiquitin signalling from lysosomal/autophagic degradation, producing accumulated, hyperfused, dysfunctional mitochondria, metabolic failure and cardiomyopathy Paper: proposed model

Critical assessment — strengths, limitations, blindspots

How this fits existing science (selected contextual citations)

• The concept that neddylation regulates mitochondrial proteins and CRL activity has precedent: reviews and experimental work have shown mitochondrial localization of neddylation components and MLN4924 alters mitochondrial morphology, ROS and respiration in other systems Review: neddylation & mitochondria
• MLN4924 is a broadly-used NAE inhibitor with systemic effects and active clinical investigation; prior literature highlights both its usefulness as a probe and the need for caution because of pleiotropy and toxicity MLN4924 discovery

Confidence, open questions, and how to falsify the central claims

Overall confidence in the central empirical findings (NAE1KO → mitochondrial hyperfusion + reduced mitophagy + cardiomyopathy) is high given the in vivo genetics and multiple orthogonal readouts; confidence in the specific molecular chain (CUL2/4b act as the critical mitochondrial CRLs) is moderate and requires additional direct substrate-level and rescue data.

Key experiments that would falsify or materially alter the conclusions:

1. If restoration of neddylation locally in cardiomyocytes (e.g., cardiac AAV-NAE1 rescue) prevented the mitochondrial and cardiac phenotypes, that would strongly support causality (positive control).
2. If proteomic mapping (NEDD8- or diGly-enriched mass spec) fails to identify mitochondrial CRL substrates, or demonstrates that mitochondrial pUb is unaffected by specific cullin mutations, it would weaken the proposed CRL-centric mechanism.
3. If MLN4924 phenotypes in primary adult human iPSC-cardiomyocytes differ from the murine genetic NAE1KO outcomes (for example, no reduction of pS65-Ub or no mitochondrial dysfunction), species/cell-type differences would limit generality.

How to strengthen and extend this work (practical experiments)

1. Mass-spectrometry of mitochondrial fractions (NEDD8-modified peptides and diGly signatures) to identify specific mitochondrial CRL substrates and ubiquitination sites; validate top candidates by mutation/rescue.
2. Rescue experiment: cardiomyocyte-specific AAV re-expression of NAE1 (or a neddylation-competent CUL2/CUL4b mutant) in NAE1KO hearts to test sufficiency for phenotype reversal.
3. Human model validation: test effects of NAE1 knockdown or MLN4924 on mitophagy (pS65-Ub, mt-Keima) in adult-like human iPSC-cardiomyocytes and adult human cardiac tissue slices to assess translational relevance.
4. Ubiquitin chain topology and PINK1/Parkin axis assays: interrogate whether PINK1 stabilization and Parkin activation are altered in NAE1KO, and characterize ubiquitin chain types (K63, K48, phospho-Ub chain recruitment dynamics) by ubiquitin linkage–specific mass spec.

Novel testable hypotheses & experiments (concise)

• Hypothesis 1: A mitochondrial-localized CUL2- or CUL4b-based CRL directly ubiquitinates a subset of OMM proteins required for pS65-Ub amplification; blocking those specific ubiquitination events is sufficient to phenocopy NAE1KO mitophagy defects. (Test: IP-mass spec of mitochondrial proteins after denaturing IP for diGly followed by siCUL2/4b.)
• Experiment 2 (intervention): AAV-mediated expression of a neddylation-resistant mutant of the putative CRL substrate (lysine→arginine) in WT hearts should alter mitophagy flux in the predicted direction; conversely, phosphomimetic/ubiquitin-mimic fusion constructs could restore mitophagy in NAE1KO if the substrate mapping is correct.

Final concise assessment & recommendations for readers

This paper is high-quality, methodologically diverse, and makes a plausible, well-supported case that neddylation is a previously underappreciated regulator of mitochondrial quality control in adult cardiomyocytes, with clear pathophysiological consequences. Researchers interested in cardiac metabolism, mitophagy, ubiquitin biology, and the cardiac safety of neddylation inhibitors should read it. Translational caution is warranted because human data are correlative and MLN4924 has broad cellular effects.

Key citations used in this review

1. Primary paper (full text)
2. Review: neddylation & mitochondria
3. MLN4924 discovery